Section 27.406. Notification requirements

A pharmacist administering injectable medications, biologicals or immunizations shall meet the following notification requirements:

(1) When administration has occurred under an order, the pharmacist shall notify the ordering prescriber as soon as practicable, but no longer than 72 hours after administration of the following:

(i) The identity of the patient.

(ii) The identity of the medication, biological or immunization administered.

(iii) The route of administration.

(iv) The site of the administration.

(v) The dose administered.

(vi) The date of administration.

(2) When the administration has occurred under a written protocol, the pharmacist shall notify the participating physician as soon as practicable, but no longer than 72 hours after administration of the following:

(i) The identity of the patient.

(ii) The identity of the medication, biological or immunization administered.

(iii) The site of the administration.

(iv) The dose administered.

(v) The date of administration.

(3) In the event of any adverse event or reaction experienced by the patient either under an order or a written protocol, the pharmacist shall notify the patient’s physician as soon as is practicable, and in no event later than 24 hours after learning of the adverse event or reaction.

The provisions of this § 27.406 adopted June 30, 2006, effective July 1, 2006, 36 Pa.B. 3237.

Notation

Authority

The provisions of this § 27.406 issued under sections 4(j), 6(k)(1) and (9), 9.1(d)(3) and (e) and 9.2(a) of the Pharmacy Act (63 P. S. § § 390-4(j), 390-6(k)(1) and (9), 390-9.1(d)(3) and (e) and 390-9.2(a)).